• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 08/01/14

    • 30-Day SEC Yield1

      1.89%
    • Total Net Assets

      $278.2M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.43%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      09/30/2014
  • Portfolio Composition (%)
    as of 08/01/14

    • % of Net Assets
    • Stocks

      100.19
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.19
  • Download All HoldingsAll Holdings (%)as of 08/01/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    285,450
    28,516,45510.25
    Novartis Ag
    NVS US
    306,805
    26,661,3559.58
    Pfizer Inc
    PFE US
    678,805
    19,791,7907.11
    Merck & Co Inc
    MRK US
    271,679
    15,431,3675.55
    Sanofi
    SNY US
    271,951
    14,465,0745.20
    Novo Nordisk A/S
    NVO US
    302,469
    13,632,2784.90
    Bristol-Myers Squibb Co
    BMY US
    257,503
    12,826,2244.61
    Abbott Laboratories
    ABT US
    302,306
    12,786,9134.60
    Teva Pharmaceutical Industries Ltd
    TEVA US
    232,629
    12,566,6194.52
    Actavis Plc
    ACT US
    57,056
    12,374,8764.45
    Eli Lilly & Co
    LLY US
    203,329
    12,338,0044.43
    Allergan Inc/United States
    AGN US
    74,105
    12,273,2704.41
    Shire Plc
    SHPG US
    47,991
    11,898,8894.28
    Glaxosmithkline Plc
    GSK US
    247,438
    11,884,4474.27
    Astrazeneca Plc
    AZN US
    162,919
    11,826,2904.25
    Abbvie Inc
    ABBV US
    222,978
    11,815,9344.25
    Mckesson Corp
    MCK US
    49,276
    9,630,0093.46
    Valeant Pharmaceuticals International I
    VRX US
    69,055
    8,162,9922.93
    Perrigo Co
    PRGO US
    31,545
    4,781,9071.72
    Mylan Inc/Pa
    MYL US
    92,406
    4,547,2991.63
    Zoetis Inc
    ZTS US
    119,564
    3,914,5251.41
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    31,082
    2,101,7650.76
    Hospira Inc
    HSP US
    35,567
    1,943,3810.70
    Salix Pharmaceuticals Ltd
    SLXP US
    10,395
    1,402,0780.50
    Questcor Pharmaceuticals Inc
    QCOR US
    13,153
    1,183,6380.43
    Other/Cash
    -520,640-0.19
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.